Vensica Medical Secures $11M in Funding to Support Phase 2 Trials for Overactive Bladder Treatment

Stock Information for Trendlines Group Ltd ADR

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Trendlines Group Ltd ADR

IBI Ag Completes $10 Million Series A Round Led by Corteva
Escala Secures $4.5M in Funding to Accelerate Global Expansion of Its FDA-Approved Medical Device
EcoPhage Appoints José Alfredo García to its Board Of Directors
Arcuro Medical Announces FDA 510(k) Clearance for the SuperBall RC for Rotator Cuff Indications
Limaca's Precision-GI(TM) Enters US Market
IBI Ag Secures $6.1 Million in Funding Round Led by Corteva Inc.
Varana Capital Leads Arcuro Medical's Series A Financing, Driving Strategic Growth in 2025
Limaca's Precision-GI(TM) Granted CMS Transitional Pass-Through (TPT) Payment

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.